Skip to main content

Table 2 Outcome measures and timing of follow-up

From: Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial

  Baseline Three-month follow-up Six-month follow-up
General characteristics X X X
MS history X X X
Medical history X X X
EDSS X X X
FIM X X X
SEIQoL-DW* X X X
Core-POS** X X X
POS-S-MS** X X X
HADS* X X X
EQ-5D* X X X
MSCQ X
Carer characteristics /medical history X X X
Carer HADS X X X
Carer SF-36 X X X
Carer EQ-5D X X X
Carer ZBI X X X
  1. To preserve blinding, all outcome measures (except MSCQ) are assessed during examiner visits at three and six months follow-up. *Not assessed in MS patients with severe cognitive compromise or unable to communicate; **carer versions used in MS patients with severe cognitive compromise or unable to communicate; assessed by phone interview. Core-POS, Core-Palliative care Outcome Scale; EDSS, Expanded Disability Status Scale; EQ-5D, European Quality of Life Five Dimensions; FIM, Functional Independence Measure; HADS, Hospital Anxiety and Depression Scale; MSCQ, Multiple Sclerosis foundation Costs Questionnaire; MS, multiple sclerosis; POS-S-MS, Palliative care Outcome Scale-Symptoms-Multiple Sclerosis; SF-36, Short Form 36; SEIQoL-DW, Schedule for the Evaluation of Individual Quality of Life-Direct Weighting; ZBI, Zarit Burden Interview.